FDA Inspection 1073636 — ALK-Abello, Inc.
The FDA completed an inspection of ALK-Abello, Inc. on November 29, 2018 in Plainville, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 29, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Plainville, CT (United States)
Additional Details
Sponsor, Contract Research Organization